c-Myc phosphorylation is required for cellular response to oxidative stress

被引:169
作者
Benassi, B
Fanciulli, M
Fiorentino, F
Porrello, A
Chiorino, G
Loda, M
Zupi, G
Biroccio, A [1 ]
机构
[1] Duke Univ, Expt Chemotherapy Lab, Durham, NC 27708 USA
[2] Duke Univ, Lab B, Expt Res Ctr, Regina Elena Canc Inst, Durham, NC 27708 USA
[3] Genoma Mol Genet Lab, Rome, Italy
[4] Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA
[5] Regina Elena Inst Canc Res, Expt Res Ctr, Mol Oncogenesis Lab, Rome, Italy
[6] Canc Genom Lab, Biella, Italy
[7] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
关键词
D O I
10.1016/j.molcel.2006.01.009
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Aside from the well-established roles of c-Myc in the regulation of cell cycle, differentiation, and apoptosis, a recent picture is beginning to emerge linking c-Myc to the regulation of metabolic pathways. Here, we define a further function for c-Myc in determining cellular redox balance, identifying glutathione (GSH) as the leading molecule mediating this process. The link between c-Myc and GSH is gamma-glutamyl-cysteine synthetase (gamma-GCS), the rate-limiting enzyme catalyzing GSH biosynthesis. Indeed, c-Myc transcriptionally regulates gamma-GCS by binding and activating the promoters of both gamma-GCS heavy and light subunits. Exposure to H2O2 enhances c-Myc recruitment to gamma-GCS regulatory regions through ERK-dependent phosphorylation. Phosphorylation at Ser-62 is required for c-Myc recruitment to gamma-GCS promoters and determines the cellular response to oxidative stress induced by different stimuli. Thus, the c-Myc phosphorylation-dependent activation of the GSH-directed survival pathway can contribute to oxidative stress resistance in tumor cells, which generally exhibit deregulated c-Myc expression.
引用
收藏
页码:509 / 519
页数:11
相关论文
共 40 条
  • [1] Transcriptional regulation and transformation by MYC proteins
    Adhikary, S
    Eilers, M
    [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2005, 6 (08) : 635 - 645
  • [2] C-myc down-regulation increases susceptibility to cisplatin through reactive oxygen species-mediated apoptosis in M14 human melanoma cells
    Biroccio, A
    Benassi, B
    Amodei, S
    Gabellini, C
    Del Bufalo, D
    Zupi, G
    [J]. MOLECULAR PHARMACOLOGY, 2001, 60 (01) : 174 - 182
  • [3] Glutathione depletion induced by c-Myc downregulation triggers apoptosis on treatment with alkylating agents
    Biroccio, A
    Benassi, B
    Fiorentino, F
    Zupi, G
    [J]. NEOPLASIA, 2004, 6 (03): : 195 - 206
  • [4] Glutathione influences c-Myc-induced apoptosis in M14 human melanoma cells
    Biroccio, A
    Benassi, B
    Filomeni, G
    Amodei, S
    Marchini, S
    Chiorino, G
    Rotilio, G
    Zupi, G
    Ciriolo, MR
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (46) : 43763 - 43770
  • [5] BINDING OF MYC PROTEINS TO CANONICAL AND NONCANONICAL DNA-SEQUENCES
    BLACKWELL, TK
    HUANG, J
    MA, A
    KRETZNER, L
    ALT, FW
    EISENMAN, RN
    WEINTRAUB, H
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (09) : 5216 - 5224
  • [6] A comparison of normalization methods for high density oligonucleotide array data based on variance and bias
    Bolstad, BM
    Irizarry, RA
    Åstrand, M
    Speed, TP
    [J]. BIOINFORMATICS, 2003, 19 (02) : 185 - 193
  • [7] Inhibitory effect of c-Myc on p53-induced apoptosis in leukemia cells.: Microarray analysis reveals defective induction of p53 target genes and upregulation of chaperone genes
    Ceballos, E
    Muñoz-Alonso, MJ
    Berwanger, B
    Acosta, JC
    Hernández, R
    Krause, M
    Hartmann, O
    Eilers, M
    León, J
    [J]. ONCOGENE, 2005, 24 (28) : 4559 - 4571
  • [8] The c-myc transactivation domain is a direct modulator of apoptotic versus proliferative signals
    Chang, DW
    Claassen, GF
    Hann, SR
    Cole, MD
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (12) : 4309 - 4319
  • [9] Myc down-regulation induces apoptosis in M14 melanoma cells by increasing p27kip1 levels
    D'Agnano, I
    Valentini, A
    Fornari, C
    Bucci, B
    Starace, G
    Felsani, A
    Citro, G
    [J]. ONCOGENE, 2001, 20 (22) : 2814 - 2825
  • [10] Dang CV, 1999, MOL CELL BIOL, V19, P1